StonvexLoading…
StonvexStonvexStonvexCore line items from MKL's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q3 2023 2023-09-30 | Q2 2023 2023-06-30 | Q1 2023 2023-03-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $3.93B | $2.60B | $1.14B | $5.24B |
Operating Income | $1.80B | $1.72B | $753.90M | $-93.34M |
Net Income | $1.23B | $1.18B | $488.65M | $-216.28M |
EPS (Diluted) | $90.69 | $87.34 | $37.26 | $-23.72 |
Total Assets | $52.75B | $52.18B | $50.94B | $49.79B |
Total Liabilities | $38.23B | $37.48B | $36.66B | $36.05B |
Cash & Equivalents | $4.35B | $4.31B | $4.03B | $4.14B |
Free Cash Flow OCF − CapEx | $1.81B | $929.18M | $247.00M | $2.45B |
Shares Outstanding | 13.41M | 13.44M | 13.47M | 13.58M |